Expressions of Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor in Tumors Induced by Two Different Cloned Cell Lines Established from Transplantable Rat Malignant Fibrous Histiocytoma

Journal of Veterinary Medical Science

Volumn 62, Issue 7, 2000, Pages 699-705

  Tsunenari, Ichiro ^a   Yamate, Jyoji ^b   Sharma, Kailash D ^a   Kawachi, Mamoru ^a   Sakuma, Sadashige ^b  

^a NIPPON BOEHRINGER INGELHEIM CO LTD   (Japan)

^b Osaka Prefecture University   (Japan)

Author keywords

Angiogenesis; bFGF; F344 rat; MFH; VEGF

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; LYMPHOKINE; VASCULOTROPIN; VASCULOTROPIN A;

ANIMAL; ARTICLE; CANCER TRANSPLANTATION; CELL CLONE; CELL CULTURE; CELL DIVISION; DERMATOFIBROMA; FISCHER 344 RAT; IMMUNOHISTOCHEMISTRY; MALE; PATHOLOGY; RAT; SARCOMA;

ANIMALS; CELL DIVISION; CLONE CELLS; ENDOTHELIAL GROWTH FACTORS; FIBROBLAST GROWTH FACTOR 2; HISTIOCYTOMA, BENIGN FIBROUS; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; MALE; NEOPLASM TRANSPLANTATION; RATS; RATS, INBRED F344; SARCOMA, EXPERIMENTAL; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034222445     PISSN: 09167250     EISSN: None     Source Type: Journal    
DOI: 10.1292/jvms.62.699     Document Type: Article

References (38)

1. Bradford, M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
2. Connolly, D.T., Heuvelman, D.M., Nelson, R., Olander, J.V., Eppley, B.L., Delfino, J.J., Siegel, N.R., Leimgruber, R.M. and Feder, J. 1989. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Invest. 84: 1470-1478.
3. Dellian, M., Witwer, B.P., Salehi, H.A., Yuan, F. and Jain, R.K. 1996. Quantitation and physiological characterization of angiogenic vessels in mice. Am. J. Pathol. 149: 59-71.
4. Dirix, L.Y., Vermeulen, P.B., Hubens, G., Benoy, I., Martin, M., Pooter, C.D. and Van Oosterom, A.T. 1996. Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancer. Ann. Oncol. 7: 843-848.
5. Enzinger, F.M. and Weiss, S.W. 1995. Malignant fibrohistiocytic tumors, pp. 351-380. In: Soft Tissue Tumors, 3rd ed. (Enzinger, F.M. and Weiss, S.W. eds.), CV Mosby, St. Louis, MO.
6. Ferrara, N. and Henzel, W.J. 1989. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 161: 851-858.
7. Folkman, J. 1971. Tumor angiogenesis: Therapeutic implications. New Engl. J. Med. 285: 1182-1186.
8. Folkman, J. 1992. The role of angiogenesis in tumor growth. Cancer Biol. 3: 65-71.
9. Folkman, J. 1994. Angiogenesis and breast cancer. J. Clin. Oncol. 12: 441-443.
10. Folkman, J. 1995. Clinical applications of research on angiogenesis. New Engl. J. Med. 333: 1757-1763.
11. Goto, F., Goto, K., Weindel, K. and Folkman, J. 1993. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab. Invest. 69: 508-517.
12. Grunt, T.W., Lametschwandtner, A., Karrer, K. and Staindl, O. 1986. The angioarchitecture of the Lewis lung carcinoma in laboratory mice (A light microscopic and scanning electron microscopic study). Scanning Electron Microsc. 2: 557-573.
13. Hamai, Y., Fujii, T., Yamashita, T., Kozuma, S., Okai, T. and Taketani, Y. 1998. Evidence for basic fibroblast growth factor as a crucial angiogenic growth factor, released from human trophoblasts during early gestation. Placenta 19: 149-155.
14. Ingber, D., Fujita, T., Kishimoto, S., Sudo, K., Kanamaru, T., Brem, H. and Folkman, J. 1990. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature (Lond) 348: 555-557.
15. Konerding, M.A., Miodonski, A.J. and Lametschwandtner, A. 1995. Microvascular corrosion casting in the study of tumor vascularity: A review. Scanning Microsc. 9: 1233-1244.
16. Landau, C., Jacobs, A.K. and Haudenschild, C.C. 1995. Intrapericardial basic fibroblast growth factor induces myocardial angiogenesis in a rabbit model of chronic ischemia. Am. Heart J. 129:924-931.
17. Mattern, J., Koomägi, R. and Volm, M. 1997. Coexpression of VEGF and bFGF in human epidermoid lung carcinoma is associated with increased vessel density. Anticancer Res. 17: 2249-2252.
18. Nakata, S., Ito, K., Fujimori, M., Shingu, K., Kajikawa, S., Adachi, W., Matsuyama, I., Tsuchiya, S., Kuwano, M. and Amano, J. 1998. Involvement of vascular endothelial growth factor and urokinase-type plasminogen activator receptor in microvessel invasion in human colorectal cancers. Int. J. Cancer (Pred. Oncol.) 79: 179-186.
19. Nguyen, M. 1997. Angiogenic factors as tumor markers. Invest. New Drugs 15: 29-37.
20. Papavassiliou, E., Gogate, N., Proescholdt, M., Heiss, J.D., Walbridge, S., Edwards, N.A., Oldfield, E.H. and Merrill, M.J. 1997. Vascular endothelial growth factor (Vascular permeability factor) expression in injured rat brain. J. Neurosci. Res. 49: 451-460.
21. Pepper, M.S., Ferrara, N., Orci, L. and Montesano, R. 1992. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem. Biophys. Res. Commun. 189: 824-831.
22. Pötgens, A.J.G., Westphal, H.R., de Waal, R.M.W. and Ruiter, D.J. 1995. The role of vascular permeability factor and basic fibroblast growth factor in tumor angiogenesis. Biol. Chem. Hoppe-Seyler 376: 57-70.
23. Segal, D.H., Germano, I.M. and Bederson, J.B. 1997. Effects of basic fibroblast growth factor on in vivo cerebral tumorigenesis in rats. Neurosurgery 40: 1027-1033.
24. Senger, D.R., Galli, S.J., Dvorak, A.M., Perruzzi, C.A., Harvey, V.S. and Dvorak, H.F. 1983. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219: 983-985.
25. Shim, J.W., Koh, Y.C., Ahn, H.K., Park, Y.E., Hwang, D.Y. and Chi, J.G. 1996. Expression of bFGF and VEGF in brain astrocytoma. J. Korean Med. Sci. 11: 149-157.
26. Shing, Y., Folkman, J., Sullivan, R., Butterfield, C., Murray, J. and Klagsbrun, M. 1984. Heparin affinity: Purification of a tumor derived capillary endothelial cell growth factor. Science 223: 1296-1299.
27. Shishido, T., Yasoshima, T., Denno, R., Mukaiya, M., Sato, N. and Hirata, K. 1998. Inhibition of liver metastasis of human pancreatic carcinoma by angiogenesis inhibitor TNP-470 in combination with cisplatin. Jpn. J. Cancer Res. 89: 963-969.
28. Skinner, S.A., Frydman, G.M. and O'brien, P.E. 1995. Microvascular structure of benign and malignant tumors of the colon in humans. Dig. Dis. Sci. 40: 373-384.
29. Sunderkotter, C., Steinbrink, K., Goebeler, M., Bhardwaj, R. and Sorg, C. 1994. Macrophages and angiogenesis. J. Leukoc. Biol. 55: 410-422.
30. Takahashi, Y., Ellis, L.M., Ohta, T. and Mai, M. 1998. Angiogenesis in poorly differentiated medullary carcinoma of the stomach. Jpn. J. Surg. 28: 367-372.
31. Towbin, H., Staehelin, T. and Gordon, J. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U.S.A. 76: 4350-4354.
32. Tsunenari, I., Yamate, J., Iwaki, M., Kuwamura, M., Kotani, T. and Sakuma, S. 1997. Angioarchitecture of tumors induced by two different cloned cell lines established from a transplantable rat malignant fibrous histiocytoma. Scanning Microsc. 11 : 473-482.
33. Tsunenari, I., Yamate, J. and Sakuma, S. 1997. Poorly differentiated carcinoma of the parotid gland in a six-week-old Sprague-Dawley rat. Toxicol. Pathol. 25: 225-228.
34. Yamate, J., Tajima, M., Shibuya, K., Ihara, M. and Kudow, S. 1989. Morphologic characteristics of a transplantable tumor derived from a spontaneous malignant fibrous histiocytoma in the rat. Jpn. J. Vet. Sci. 51: 587-596.
35. Yamate, J., Tajima, M., Shibuya, K., Kuwamura, M., Kotani, T. and Sakuma, S. 1996. Phenotypic modulation in cisplatin-resistant cloned cells derived from transplantable rat malignant fibrous histiocytoma. Pathol. Int. 46: 557-567.
36. Yamate, J., Tajima, M., Shibuya, K., Kuwamura, M., Kotani, T., Sakuma, S. and Takeya, M. 1996. Heterogeneity in the origin and immunophenotypes of "Histiocytic" cells in transplantable rat malignant fibrous histiocytoma. J. Vet. Med. Sci. 58: 603-609.
37. Yamate, J., Tajima, M., Shibuya, K. and Saitoh, T. 1994. Enhancement of lipid phagocytosis by cloned cells derived from rat malignant fibrous histiocytoma under hyperlipemic conditions. Pathol. Int. 44: 735-744.
38. Yamate, J., Tajima, M., Togo, M., Shibuya, K., Ihara, M. and Kudow, S. 1991. Heterogeneity of cloned cell lines established from a transplantable rat malignant fibrous histiocytoma. Jpn. J. Cancer Res. 82: 298-307.